| Line item | 2026-01-31 FY | 2025-01-31 FY | 2024-01-31 FY | 2023-01-31 FY | 2022-01-31 FY | 2021-01-31 FY |
|---|---|---|---|---|---|---|
| Revenue | – | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – | – |
| Gross Profit | – | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – | – |
| R&D | – | – | – | – | – | – |
| SG&A | – | – | – | – | – | – |
| Operating Income | -$921.84K | -$636.74K | – | – | – | – |
| Interest Expense | – | – | – | – | – | – |
| Tax Expense | – | – | – | – | – | – |
| Net Income | – | -$633.17K | -$523.90K | -$903.04K | -$34.41M | -$643.23K |
| EPS (basic) | – | – | – | – | – | – |
| EPS (diluted) | – | – | – | – | – | – |
| Shares (diluted) | – | – | – | – | – | – |